EAGLE ASSET MANAGEMENT INC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 279 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$20,067,334
+24.2%
198,982
+67.3%
0.12%
+32.2%
Q2 2023$16,163,571
+41.2%
118,946
+7.9%
0.09%
+34.3%
Q1 2023$11,451,000
+19.9%
110,260
+3.6%
0.07%
+13.6%
Q4 2022$9,549,000
+31.2%
106,396
+17.2%
0.06%
+22.9%
Q3 2022$7,280,000
-83.0%
90,808
-79.7%
0.05%
-82.1%
Q2 2022$42,742,000
-43.8%
446,355
-12.8%
0.27%
-31.1%
Q1 2022$76,042,000
+2.8%
511,898
-0.8%
0.39%
+20.1%
Q4 2021$73,985,000
+6.0%
516,225
-3.2%
0.32%
+2.9%
Q3 2021$69,784,000
-9.4%
533,401
-4.9%
0.32%
-4.8%
Q2 2021$77,051,000
-11.4%
560,657
-16.5%
0.33%
-14.0%
Q1 2021$86,960,000
+19.6%
671,353
+3.4%
0.38%
-6.1%
Q4 2020$72,727,000
+107.4%
649,350
+42.8%
0.41%
+126.5%
Q3 2020$35,068,000
+10.5%
454,728
-0.5%
0.18%
+0.6%
Q2 2020$31,728,000
+25.9%
457,116
+3.9%
0.18%
+14.6%
Q1 2020$25,196,000
-44.8%
439,959
+7.7%
0.16%
-28.3%
Q4 2019$45,681,000
+32.6%
408,495
+14.0%
0.22%
+23.0%
Q3 2019$34,443,000
+231.2%
358,231
+194.7%
0.18%
+235.8%
Q2 2019$10,401,000
+34.8%
121,551
+31.1%
0.05%
+29.3%
Q1 2019$7,715,000
-43.5%
92,751
-70.0%
0.04%
-44.6%
Q2 2014$13,643,000
-1.6%
309,020
-3.1%
0.07%
-2.6%
Q1 2014$13,858,000318,9640.08%
Other shareholders
CONMED CORP shareholders Q1 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 310,392$34,764,0004.40%
Iron Triangle Partners LP 148,317$16,612,0002.15%
Ranger Investment Management 294,664$33,002,0001.74%
Penn Capital Management Company, LLC 86,810$9,723,0001.23%
EARNEST PARTNERS LLC 1,575,336$176,438,0001.22%
Champlain Investment Partners, LLC 1,692,014$189,506,0001.09%
MOODY ALDRICH PARTNERS LLC 59,005$6,609,0001.07%
Hood River Capital Management LLC 232,412$26,030,0000.86%
OAK RIDGE INVESTMENTS LLC 80,775$9,047,0000.80%
Huber Capital Management LLC 18,620$2,085,0000.68%
View complete list of CONMED CORP shareholders